The potential utility of cord blood DNA methylation in pediatric clinical practice

Area of Science:

• Environmental epigenetics
• Developmental origins of health and disease (DOHaD)
• Pediatric chronic disease

Background:

• Understanding noncommunicable disease origins increasingly incorporates prenatal and preconceptional influences.
• Parental exposures like diet, obesity, and gestational diabetes are linked to infant/fetal methylome alterations.
• These epigenetic changes suggest associations with long-term child health outcomes.

Purpose of the Study:

• To explore the utility of cord blood DNA methylation as a biomarker for pediatric disease risk.
• To discuss the challenges and opportunities in translating epigenetic findings into clinical practice.

Main Methods:

• Review of research associating parental exposures with infant/fetal methylome.
• Discussion of epigenetic mechanisms linking early-life exposures to chronic disease.
• Analysis of the requirements for clinical biomarker validation.

Main Results:

• Cord blood DNA methylation shows potential as a biomarker for disease risk identification in pediatrics.
• Replicability, validation, and clinical meaningfulness are crucial for biomarker implementation.
• Significant challenges and opportunities exist in leveraging epigenetics for pediatric health.

Conclusions:

• Epigenetics, particularly cord blood DNA methylation, offers a promising avenue for early disease risk assessment in children.
• Further research and validation are necessary to integrate these epigenetic biomarkers into pediatric clinical practice.